FIELD: pharmaceutical industry.
SUBSTANCE: group of inventions relates to an agent for treating urinary incontinence. Use of the pharmaceutical composition for treating urinary incontinence, where the pharmaceutical composition contains an effective dose of 1-[2-({[trans-3-fluoro-1-(3-fluoropyridin-2-yl)cyclobutyl]methyl}amino)pyrimidin-5-yl]-1H-pyrrol-3-carboxamide and a pharmaceutically acceptable excipient. Application of effective dose of 1-[2-({[trans-3-fluoro-1-(3-fluoropyridin-2-yl)cyclobutyl]methyl}amino)pyrimidin-5-yl]-1H-pyrrole-3-carboxamide for treatment urinary incontinence. Method of treating urine incontinence, comprising administering an effective dose of 1-[2-({[trans-3-fluoro-1-(3-fluoropyridin-2-yl)cyclobutyl]methyl}amino)pyrimidin-5-yl]-1H-pyrrole-3-carboxamide to a patient, in need thereof.
EFFECT: above described agent is effective for treating urinary incontinence.
9 cl, 2 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEW AIR OF FLUORIDATED BENZYLIC ACID AND ITS SALT | 2014 |
|
RU2632881C2 |
| NOVEL ACETIC ACID ESTER OR SALT THEREOF | 2013 |
|
RU2585759C2 |
| METHOD FOR TREATING THE CASES OF MALE ENURESIS | 2003 |
|
RU2243729C1 |
| TISSUE FRAGMENT COMPOSITIONS FOR INCONTINENCE | 2008 |
|
RU2459627C2 |
| PDE INHIBITORS AND THEIR COMBINATIONS FOR TREATMENT OF UROLOGIC DISORDERS | 2006 |
|
RU2435588C2 |
| COMPOSITION FOR TREATMENT AND/OR PREVENTION OF LOWER URINARY TRACT SYMPTOMS | 2020 |
|
RU2808426C2 |
| METHOD OF MINIMALLY INVASIVE TREATMENT OF STRESS URINARY INCONTINENCE IN WOMEN | 2018 |
|
RU2748118C1 |
| AGENT REDUCING INTENSITY OF DETRUSOR WITH IMPAIRED CONTRACTILITY | 2016 |
|
RU2714444C2 |
| CYSTOSCOPIC TREATMENT OF HORMONE-DEPENDENT SPHINCTER INSUFFICIENCY OF THE BLADDER IN FEMALE DOGS | 2021 |
|
RU2755278C1 |
| METHOD OF TREATING URINARY INCONTINENCE IN MALES COMBINED WITH URETHRAL STRICTURE | 2020 |
|
RU2735893C2 |
